Replies to post #671773 on NorthWest Biotherapeutics Inc (NWBO)

[Poor Man -]

I’ve made this point many times over the years: the biggest problem for shareholders is that the stock is traded as an OTC. That limits institutional investment. I could list ten other reasons why it only takes loose change to buy a share of NWBO. But I’ll demure.

It’s very uncommon for an OTC stock not listed on an another major foreign exchange to have market caps exceeding $ billion — NWBO’s market cap is actually very good for an OTC stock, but the dilution doesn’t allow that to be reflected in the stock price. Note: The Frankfurt exchanged that NWBO is listed is the German version of their OTC.

Let’s also be clear, the MTD for the spoofing case has been granted for the time being. Not clear the case will survive at all.

[Horseb4CarT]

The sp is under manipulative control until the grip is broken, hopefully soon this year.

Then the true value will begin to be realized imho.

[polska]

The relentless social media campaign to malign NWBO is also telling.